Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsA new coronavirus vaccine heading to India was developed by a small team in Texas. It expects nothin
Dr. Hotez is amazing. He spoke to my temple during High Holy Days services
Link to tweet
For some vaccine developers, the coronavirus pandemic has had a silver lining in billions of dollars in profits. But a new vaccine rolling out soon in India is taking the opposite approach: Its developers are getting zilch.
Were not trying to make money, said Peter Hotez of the Texas Childrens Hospitals Center for Vaccine Development. We just want to see people get vaccinated.
On Tuesday, the Indian government granted emergency approval to a vaccine manufactured by the Hyderabad-based company Biological E. This second generation coronavirus vaccine was developed by Hotez and his longtime collaborator Maria Elena Bottazzi. It was then licensed to Biological E. through a commercialization team at Baylor College of Medicine in Houston, where both developers also work.
Biological E. has ambitious plans to produce more than 1 billion doses of the vaccine in 2022. Hotez and Bottazzi wont personally get a penny from it, but their employer Baylor College will get a fee.
Were not trying to make money, said Peter Hotez of the Texas Childrens Hospitals Center for Vaccine Development. We just want to see people get vaccinated.
On Tuesday, the Indian government granted emergency approval to a vaccine manufactured by the Hyderabad-based company Biological E. This second generation coronavirus vaccine was developed by Hotez and his longtime collaborator Maria Elena Bottazzi. It was then licensed to Biological E. through a commercialization team at Baylor College of Medicine in Houston, where both developers also work.
Biological E. has ambitious plans to produce more than 1 billion doses of the vaccine in 2022. Hotez and Bottazzi wont personally get a penny from it, but their employer Baylor College will get a fee.
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
3 replies, 824 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (19)
ReplyReply to this post
3 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
A new coronavirus vaccine heading to India was developed by a small team in Texas. It expects nothin (Original Post)
LetMyPeopleVote
Dec 2021
OP
"We're not trying to make money. We just want to see people get vaccinated."
LetMyPeopleVote
Jan 2022
#2
NQAS
(10,749 posts)1. That's great
Whats the colleges fee?
LetMyPeopleVote
(145,291 posts)2. "We're not trying to make money. We just want to see people get vaccinated."
dalton99a
(81,514 posts)3. Kick